0001354457-16-000551.txt : 20161110
0001354457-16-000551.hdr.sgml : 20161110
20161110101940
ACCESSION NUMBER: 0001354457-16-000551
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20161110
DATE AS OF CHANGE: 20161110
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Stereotaxis, Inc.
CENTRAL INDEX KEY: 0001289340
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 943120386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50884
BUSINESS ADDRESS:
STREET 1: 4320 FOREST PARK AVENUE
STREET 2: SUITE 100
CITY: ST.LOUIS
STATE: MO
ZIP: 63108
BUSINESS PHONE: 314-678-6100
MAIL ADDRESS:
STREET 1: 4320 FOREST PARK AVENUE
STREET 2: SUITE 100
CITY: ST.LOUIS
STATE: MO
ZIP: 63108
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NASDAQ Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
25-NSE
1
primary_doc.xml
X0203
0001354457
NASDAQ Stock Market LLC
0001289340
Stereotaxis, Inc.
000-50884
4041 Forest Park Avenue, Suite 100
St. Mouis
MO
MISSOURI
63108
314 615-6940
Common Stock
17 CFR 240.12d2-2(b)
Amy Horton
Hearings Advisor
2016-11-10
EX-99.25
2
stxsdelistreason.txt
Delisting Determination,The Nasdaq Stock Market, LLC,
November 10, 2016, Stereotaxis, Inc. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the common stock of Stereotaxis, Inc.
(the Company), effective at the opening of the trading
session on November 21, 2016. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5550(b)(2).
The Company was notified of the Staffs determination on
February 2, 2016. The Company appealed the determination
to a Hearing Panel. Upon review of the information provided
by the Company, the Panel issued a decision dated
May 2, 2016, granting the Company continued listing
pursuant to an exception that included several milestones
that the Company was required to meet, towards the toal
of regaining compliance with Listing Rule 5550(b)(2).
However, the Company was
unable to meet the exception milestones as required.
On August 2, 2016, the Panel issued a final delisting
determination and notified the Company that trading in the Companys
securities would be suspended on August 4, 2016.
The Company did not request a review of the Panels decision
by the Nasdaq Listing and Hearing Review Council. The
Listing Council did not call the matter for review.
The Panels Determination to delist the Company
became final on September 16, 2016.